Literature DB >> 16339967

LEM2 is a novel MAN1-related inner nuclear membrane protein associated with A-type lamins.

Andreas Brachner1, Siegfried Reipert, Roland Foisner, Josef Gotzmann.   

Abstract

The LEM (lamina-associated polypeptide-emerin-MAN1) domain is a motif shared by a group of lamin-interacting proteins in the inner nuclear membrane (INM) and in the nucleoplasm. The LEM domain mediates binding to a DNA-crosslinking protein, barrier-to-autointegration factor (BAF). We describe a novel, ubiquitously expressed LEM domain protein, LEM2, which is structurally related to MAN1. LEM2 contains an N-terminal LEM motif, two predicted transmembrane domains and a MAN1-Src1p C-terminal (MSC) domain highly homologous to MAN1, but lacks the MAN1-specific C-terminal RNA-recognition motif. Immunofluorescence microscopy of digitonin-treated cells and subcellular fractionation identified LEM2 as a lamina-associated protein residing in the INM. LEM2 binds to the lamin C tail in vitro. Targeting of LEM2 to the nuclear envelope requires A-type lamins and is mediated by the N-terminal and transmembrane domains. Highly overexpressed LEM2 accumulates in patches at the nuclear envelope and forms membrane bridges between nuclei of adjacent cells. LEM2 structures recruit A-type lamins, emerin, MAN1 and BAF, whereas lamin B and lamin B receptor are excluded. Our data identify LEM2 as a novel A-type-lamin-associated INM protein involved in nuclear structure organization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339967     DOI: 10.1242/jcs.02701

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  55 in total

Review 1.  Many mechanisms, one entrance: membrane protein translocation into the nucleus.

Authors:  Nikolaj Zuleger; Alastair R W Kerr; Eric C Schirmer
Journal:  Cell Mol Life Sci       Date:  2012-02-12       Impact factor: 9.261

Review 2.  Lamin-binding Proteins.

Authors:  Katherine L Wilson; Roland Foisner
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-17       Impact factor: 10.005

3.  MEL-28/ELYS is required for the recruitment of nucleoporins to chromatin and postmitotic nuclear pore complex assembly.

Authors:  Cerstin Franz; Rudolf Walczak; Sevil Yavuz; Rachel Santarella; Marc Gentzel; Peter Askjaer; Vincent Galy; Martin Hetzer; Iain W Mattaj; Wolfram Antonin
Journal:  EMBO Rep       Date:  2007-01-19       Impact factor: 8.807

Review 4.  Traversing the NPC along the pore membrane: targeting of membrane proteins to the INM.

Authors:  Wolfram Antonin; Rosemarie Ungricht; Ulrike Kutay
Journal:  Nucleus       Date:  2011 Mar-Apr       Impact factor: 4.197

Review 5.  Evolvement of LEM proteins as chromatin tethers at the nuclear periphery.

Authors:  Andreas Brachner; Roland Foisner
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

Review 6.  Barrier to Autointegration Factor (BANF1): interwoven roles in nuclear structure, genome integrity, innate immunity, stress responses and progeria.

Authors:  Augusta Jamin; Matthew S Wiebe
Journal:  Curr Opin Cell Biol       Date:  2015-06-10       Impact factor: 8.382

Review 7.  Nuclear membrane diversity: underlying tissue-specific pathologies in disease?

Authors:  Howard J Worman; Eric C Schirmer
Journal:  Curr Opin Cell Biol       Date:  2015-06-24       Impact factor: 8.382

Review 8.  Partners and post-translational modifications of nuclear lamins.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Chromosoma       Date:  2013-03-12       Impact factor: 4.316

9.  The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections.

Authors:  Alok Mulky; Tatiana V Cohen; Serguei V Kozlov; Barbara Korbei; Roland Foisner; Colin L Stewart; Vineet N KewalRamani
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

10.  Cell-specific and lamin-dependent targeting of novel transmembrane proteins in the nuclear envelope.

Authors:  Poonam Malik; Nadia Korfali; Vlastimil Srsen; Vassiliki Lazou; Dzmitry G Batrakou; Nikolaj Zuleger; Deirdre M Kavanagh; Gavin S Wilkie; Martin W Goldberg; Eric C Schirmer
Journal:  Cell Mol Life Sci       Date:  2010-01-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.